Lyell Immunopharma Inc
|Market Cap (Intraday)||3.17B|
|2yr Forward PE||N/A|
Lyell Immunopharma Inc Stock, NASDAQ:LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.